Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023
Nominations recognize innovative development of AVERSA™ abuse-deterrent transdermal technologyORLANDO, FL / ACCESSWIRE / September 12, 2023 / Nutriband Inc. (the...
Year: 2023
AlayaCare Announces Partnership and Technology Integration with Virtuose Technologies
MONTREAL, QC / ACCESSWIRE / September 12, 2023 / AlayaCare, an industry-leading end-to-end platform for home-based care, today announced its...
Nordic Naturals Expands Retail Presence with Exclusive Omega-3 Supplement Offerings Coming to Sam’s Club Stores in October
Nordic Naturals Ultimate Omega at Sam's Club Nordic Naturals’ Ultimate Omega 100 count omega-3 supplements will be available exclusively in...
Visory Health Executive, Brittney Tierce, Recognized by 2023 OC Inspirational Women Forum and Leadership Awards
Tierce was honored for her innovative work in developing the first cloud-based adjudication system to help lower prescription costs across...
BioRestorative Therapies Enters into Supply Agreement with Evolutionary Biologics
--BioRestorative to Leverage its Core Competencies in Cell Biology and Manufacturing to Supply Biologics for Cosmetic Applications in Strategic Agreement...
SomaLogic researchers identify key proteins to aid in early detection of lung, colon and breast cancer and ovarian tumors
SomaLogic’s SomaScan® platform was used to target 15 markers shared among all cancer types.BOULDER, Colo., Sept. 12, 2023 (GLOBE NEWSWIRE)...
Sorrento Announces Phase 3 Trial Met Primary Endpoint and Key Secondary Endpoint in Mild or Moderate COVID-19 Adult Patients Treated with Ovydso (Olgotrelvir), an Oral Mpro Inhibitor as a Standalone Treatment for COVID-19
In the phase 3 trial, a randomized double blind and placebo-controlled pivotal study, 1,212 mild or moderate COVID-19 patients were...
Scilex Holding Company Presented Oral and Poster Presentations on Elyxyb at the 2023 Annual Brain Week Conference Held in Las Vegas, NV
PALO ALTO, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), a majority-owned subsidiary...
Scilex Holding Company Presented Oral and Poster Presentations on ZTlido (lidocaine topical system) at the 2023 Annual PAINWeek Conference Held in Las Vegas, NV
PALO ALTO, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), a majority-owned subsidiary...
NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS
CARMEL, Ind., Sept. 12, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
Portal provides resources to raise awareness around mental health and suicide preventionMALVERN, Pa., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics,...
Healthcare Triangle to Host Webinar Addressing Ransomware Preparedness for Healthcare
Key learnings for today’s event include methods for securing patient care and data integrity amid evolving cybersecurity challenges Lena Kannappan...
Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
JERUSALEM, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX, “Entera”) and OPKO Biologics, Inc., a subsidiary of...
GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies Group
GelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security MarketMIAMI, Sept. 12, 2023 (GLOBE...
Bioskills of the North East (BONE) Announces Alexander Kouspakian as New CEO
Healthcare Industry Veteran Brings Relentless Drive for Innovation and Customer-Centric approach to Medical Device and Training Facility ALEXANDER KOUSPAKIAN Alexander...
Bolt Biotherapeutics Announces Issuance of U.S. Patent Covering Dectin-2-Targeting Agonist Antibodies, Including BDC-3042
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel...
IO Biotech Announces New Data Related to its IO102-IO103 Therapeutic Cancer Vaccine Presented Today at the IASLC 2023 World Conference on Lung Cancer
Encouraging interim data support the potential of IO102-IO103 in combination with pembrolizumab as first-line treatment in non-small cell lung cancerNEW...
A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC
• Data presented at the 2023 World Conference on Lung Cancer hosted by the International Association for the Study of...
Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
New Test Analyzes Highly Curated Set of 236 Genes Most Associated with Autism Spectrum Disorder, Intellectual Disabilities, and Developmental Delay.HOUSTON,...
Spinogenix Awarded $3 Million NIH Grant to Support Continued Development of SPG302, the First Synaptic Regenerative Therapeutic for Alzheimer’s Disease
Treatment Could Help Restore Brain Functions Lost in Many Neurogenerative DisordersSAN DIEGO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Spinogenix, Inc.,...